Petra A Wark1, Rosa Lau, Teresa Norat, Ellen Kampman. 1. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. p.wark@imperial.ac.uk
Abstract
BACKGROUND: Dietary magnesium might be related to colorectal tumor risk through the pivotal roles of magnesium in cellular metabolism, insulin resistance, and systemic inflammation. OBJECTIVE: We evaluated the hypothesis of whether higher dietary magnesium intake is associated with reduced colorectal tumor risk. DESIGN: A case-control study on colorectal adenomas (768 cases; 709 polyp-free control subjects) and a meta-analysis of colorectal adenomas (3 case-control studies) and carcinomas (6 prospective cohort studies) were conducted. Dietary magnesium was estimated from food-frequency questionnaires in the case-control study and most studies in the meta-analyses. Data analysis comprised multiple logistic regression analysis (case-control study) and fixed- and random-effects meta-analyses. RESULTS: The case-control study showed a nonsignificant inverse association between dietary magnesium intake and risk of colorectal adenomas (OR for every 100-mg/d increase: 0.81; 95% CI: 0.62, 1.06). However, inverse associations were observed only in subjects with BMI (in kg/m²) ≥25, in subjects aged ≥55 y, and for advanced adenomas. Associations did not vary by the calcium-to-magnesium intake ratio. In the meta-analysis, every 100-mg/d increase in magnesium intake was associated with 13% lower risk of colorectal adenomas (OR: 0.87; 95% CI: 0.75, 1.00) and 12% lower risk of colorectal cancer (RR: 0.88; 95% CI: 0.81, 0.97). CONCLUSIONS: Our findings support the hypothesis that higher intakes of dietary magnesium are associated with lower risk of colorectal tumors. The consumption of magnesium-rich foods may be a new avenue to explore further in the search for cancer-prevention strategies.
BACKGROUND: Dietary magnesium might be related to colorectal tumor risk through the pivotal roles of magnesium in cellular metabolism, insulin resistance, and systemic inflammation. OBJECTIVE: We evaluated the hypothesis of whether higher dietary magnesium intake is associated with reduced colorectal tumor risk. DESIGN: A case-control study on colorectal adenomas (768 cases; 709 polyp-free control subjects) and a meta-analysis of colorectal adenomas (3 case-control studies) and carcinomas (6 prospective cohort studies) were conducted. Dietary magnesium was estimated from food-frequency questionnaires in the case-control study and most studies in the meta-analyses. Data analysis comprised multiple logistic regression analysis (case-control study) and fixed- and random-effects meta-analyses. RESULTS: The case-control study showed a nonsignificant inverse association between dietary magnesium intake and risk of colorectal adenomas (OR for every 100-mg/d increase: 0.81; 95% CI: 0.62, 1.06). However, inverse associations were observed only in subjects with BMI (in kg/m²) ≥25, in subjects aged ≥55 y, and for advanced adenomas. Associations did not vary by the calcium-to-magnesium intake ratio. In the meta-analysis, every 100-mg/d increase in magnesium intake was associated with 13% lower risk of colorectal adenomas (OR: 0.87; 95% CI: 0.75, 1.00) and 12% lower risk of colorectal cancer (RR: 0.88; 95% CI: 0.81, 0.97). CONCLUSIONS: Our findings support the hypothesis that higher intakes of dietary magnesium are associated with lower risk of colorectal tumors. The consumption of magnesium-rich foods may be a new avenue to explore further in the search for cancer-prevention strategies.
Authors: Shailja C Shah; Qi Dai; Xiangzhu Zhu; Richard M Peek; Walter Smalley; Christianne Roumie; Martha J Shrubsole Journal: Int J Cancer Date: 2019-10-12 Impact factor: 7.396
Authors: Elizabeth J Polter; Guillaume Onyeaghala; Pamela L Lutsey; Aaron R Folsom; Corinne E Joshu; Elizabeth A Platz; Anna E Prizment Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-06-05 Impact factor: 4.254
Authors: Xiangzhu Zhu; Martha J Shrubsole; Reid M Ness; Elizabeth A Hibler; Qiuyin Cai; Jirong Long; Zhi Chen; Guoliang Li; Ming Jiang; Lifang Hou; Edmond K Kabagambe; Bing Zhang; Walter E Smalley; Todd L Edwards; Edward L Giovannucci; Wei Zheng; Qi Dai Journal: Mol Carcinog Date: 2015-08-31 Impact factor: 4.784
Authors: Meng-Hua Tao; Qi Dai; Amy E Millen; Jing Nie; Stephen B Edge; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim Journal: Am J Cancer Res Date: 2015-12-15 Impact factor: 6.166